Quanterix Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances
Quanterix Corporation (QTRX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances of $800.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues · last filed 2025-11-10
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, issuances for the quarter ending 2025-09-30 was $0.00.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, issuances for the quarter ending 2025-06-30 was $0.00.
- Quanterix Corporation fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, issuances for the quarter ending 2025-03-31 was $800.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances 9 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $800.00K 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $800.00K 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $800.00K 10-Q · filed 2025-05-12 | ||||
| 2023-06-26 | $800.00K 10-K/A · filed 2024-12-26 | $1.00M 10-Q · filed 2023-11-08 | |||
| 2023-06-23 | $1.00M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |